Skip navigation Jump to main navigation

The FDA vs. 23andMe: A Lesson for Health Care Entrepreneurs

Due to the number of unknowns about genetics, the benefits of consumer genetic testing are questionable, states Robert Klitzman, Director of the M.S. in Bioethics program, in this look at the 23andMe controversy from a marketing standpoint.

Read More

Related News

All News
All News